Loading...
Loading...
CDC PLACES (2023, crude) estimates 14.6% of adults in Kansas City have diagnosed diabetes — 2.6 points above the U.S. 12% figure. Census population 156,607. Kansas Medicare wound biologics: WPS Government Health Administrators (J5). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Kansas City clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Kansas City storefront.
361 HCT/P Compliant Tissue Products in Kansas City, KS for clinics & physicians. Exclusively 361 HCT/P com… Compliance support & pricing — contact Hawk Medical.
Kansas City is a city under 250k (156,607 Census). CDC PLACES (2023, crude) estimates 14.6% of adults in Kansas City have diagnosed diabetes — 2.6 points above the U.S. 12% figure. Adult arthritis here is 23.3% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Keep 361 tissue, autologous PRP, and skin substitutes on different tickets. We onboard against that split — then ship.
National 361 HCT/P Compliant Tissue Products notes (how the product actually works)J5 reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Kansas City is 14.6% or not. PLACES is planning data. The LCD is the claim.
We are not going to invent a Kansas City warehouse or a five-star local review. What you get is 361 hctp compliant products from FDA-registered sources, lot paperwork, and someone who has run the same SOPs in clinic — Joe Bradley. The local numbers on this page are CDC PLACES and CMS J5, not marketing adjectives.
CDC PLACES (2023, crude prevalence) estimates 14.6% of adults — 2.6 points above the U.S. 12% figure. Obesity is 41.2%; arthritis is 23.3%. That is place-level BRFSS modeling, not a clinic census and not a Kansas City trial.
No. Hematogel is a PRP-based wound gel pathway with its own application and documentation. Skin substitutes/CTPs follow WPS Government Health Administrators CTP articles. Mixing those codes is a billing error.
Joe Bradley, Founder & CEO of Hawk Medical LLC, is an active clinical practice owner. These programmatic pages are distribution resources for providers, reviewed against the same HCT/P and wound-care portfolio used in that practice. They are not patient treatment advice.
No. areaServed names the city we will ship to. It is not a claim that Hawk Medical is a Kansas City medical practice or that we hold a local facility license.
If you operate in Kansas and another MAC state, say it on the first call. J5 will not port 1:1. We would rather split utilization than watch a sister clinic copy Kansas City tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Kansas City, KS.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Kansas City is J5 geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Kansas City — 2.6 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Kansas Part B wound biologics follow this contractor (siblings: IA, MO, NE). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Kansas City. Useful for joint-program math; still needs a diagnosis and privileging.
No Kansas City storefront. Joe Bradley is an active practice owner. 361 hctp compliant products stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.